Equasens (STU:PHF) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:PHF Equasens STU:PHF
79 GF Score
Price €33.20
GF Value €56.20
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Equasens FFO per Share?

FFO per Share only applies to REITs.

STU:PHF
79GF Score
Equasens STU:PHF
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Equasens (STU:PHF) Overvalued in 2026?

Based on GuruFocus' analysis, Equasens stock appears to be undervalued. The current stock price of €33.20 is trading 40.9% below its estimated GF Value™ of €56.20. GuruFocus considers Equasens to be Significantly Undervalued.

Key valuation signals for STU:PHF:

  • FFO per Share:
  • GF Value™: €56.20 vs. price of €33.20 (40.9% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the STU:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Equasens Business Description

Other Exchanges EQSp:UK0R9T:UKEQS:France
Address 5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
79GF Score

Get the complete analysis for STU:PHF

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€33.20
Price
€56.20
GF Value